ÃâÒßѧÊÔÌâ
4w( vRe Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
N1~V +_mM 1. Fas(CD95)/FasL
(AG 2. common chain of cytokine receptor
Sx)Il~ x 3 . TCR/CD3 complex
Qc;[mxQe 4. negaive selection of thymocytes
&H&P)Px*_ 5. artificial active immune
r`&|)
Hx 6. anti-idiotypic
50ew/fZj| 7. IgSF
"O[76}I+.q 8. Integrin
6KCmswvE 9. chemokine
2A}u qaF 10. B7/CD28
SMO%sZ] ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
0? us]lx 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
CQ
Hp4
_ 2. ±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌص㡣
GR ?u?- 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆʵÑé·½°¸¿Ë¡´Ë»ùÒò¡£
(}
X?v`Y^W 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
Hu9R.[u DRW.NL o 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
Qf-k&d µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
y3nm!tjyM Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
H='9zqYZ<W 1. B7/CD28
GoSWH2N 2. Th1 subset
As'M39*V 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
.x!7 4. antibody affinity maturation
abaQJ| 5. AP-1
@`;Y/', 6. single chain variable fragment£¨ScFv£©
o`K^Wy~+k# 7. NK cell receptor
kE_@5t7O{
8. Zinkernagel-Doherty phenomenon
K-EI?6`xM 9. Ig fold
0"^oTmQN 10. CD40/CD40L
JXY!c\, ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
CoUd16*"JM 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØϵ¡£
BY4 R@) 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
&&9c&xgzE 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹Øϵ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
JQ@`EV9, Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
HcBH!0 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁÜ°Íϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
< k+fKl 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
?St=7a(D 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æרҵ£©¡£
~f=6?5.wa Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
/SCZ& £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
:%uyy5A
Z Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
|.8d,!5w} 1.Co-stimulators (or co-stimulating molecules)
11B{gUv.] 2.NK-kB
pKxX{i1l 3.Immunoglobulin superfamily
sw$R2K{y 4.antigen-presenting cell (APC)
&6\r 5.death domain
:^H9W^2 6.CCR and CXCR
T+K` ^xv_L 7.Lectin (or mitogen)
w%8ooQ|C 8.Clusters of differentiation, CD)
Zr.\`mG4f 9.B7 family
&N/|(<C
B 10.Cytotoxic T lymphocyte, CTL)
)
]/i 11.IL-15 and IL-15 receptor (IL-15R)
k+WO &g*| 12.MHC restriction
s`Yu"s
8}4 13.Affinity-chromatography
agU%z:M{ 14.Cyctosprin A, CsA
:$M9XZ~\ 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
DMAf^.,S ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
,30FGz^i 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
M.xhVgFf) 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£
XlPK3^'N)h 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣
@4/~~ Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
1P[I}GW# ÃâÒßѧרҵ£º
Q$xa 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
g[#k.CuP Ïû»¯ÄÚ¿Æ£º
pBSq%Hy: 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
6C
cB-@n4 ѪҺ²¡Ñ§×¨Òµ£º
0kU3my] 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
22)0zY%\ Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
.mvB99P{< (רҵ»ù´¡: ÃâÒßѧ)
J 6(~>g
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
t{/:( Nu 1. ADCC(antibody dependent cell-mediated cytotoxicity)
"XGD:>Q. 2. »·æß¾úËØ(cyclosporin)
Np.no$_ 3. KIR(killer cell inhibitory receptor)
rnnX|}J 4. HLDA(human leucocyte differentiation antigen)
cJxW;WI!, 5. Interleukin 18(IL-18)
8g<Q5( 6. ÕûºÏËØ(integrin)
\@Ee9C13 7. Fas/FasL
J"%8:pL 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
hMNJ'i} 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
y=[gQJ6~r
10. Th1/Th2
w+t# Yb\7 11. »ùÒòÒßÃç(DNAÒßÃç)
n11LxGwk 12. chemokines and chemokine receptor
<e;jWK 13. ÃâÒßÄÍÊÜ
f=t:[<
) 14. ¹²´Ì¼¤·Ö×Ó
f"vk# 3 15. ËÀÍö½á¹¹Óò(death domain)
)D:9R)m ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
1)$%
Jr 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉË°Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
Xl#Dw bx 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»Æƶø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
JT4wb]kdV £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
:~vxZ*a £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
j3
6,w[Y: £¨3£©1984Ä꣺ÁÜ°Íϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
J5O.*& £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
Dt
W*n1Bt 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄЩÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
#"::
'?, Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
Takt_N ÎÊ´ðÌâ(ÿÌâ25·Ö)
h aCKv 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
Ffnk1/Zy 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
XcOA)'Py 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆһϵͳʵÑé,¼ÓÒÔ֤ʵ¡£
J5;5-:N 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃÇ°¾°¡£